Online Only

Online Only
AVBCC 2021 Highlights
The Impact of Telehealth on Cancer Care
Read More
Online Only
AVBCC 2021 Highlights
Medically Integrated Oncology Pharmacy Promotes Patient-Centric Care
Read More
Online Only
AVBCC 2021 Highlights
Drug Price Reform with Value in Mind: Can It Happen?
Read More
Online Only
AVBCC 2021 Highlights
Using Value-Based Contracts to Manage Oncology Costs While Keeping Focus on the Patient
Read More
Online Only
FDA Approvals
Tabrecta (Capmatinib) First FDA-Approved Drug for Metastatic NSCLC with MET Exon 14 Skipping Mutation
Loretta Fala
Loretta Fala
Read More
Online Only
FDA Approvals
Ukoniq (Umbralisib) FDA Approved for Adults with Relapsed or Refractory Marginal-Zone Lymphoma or Follicular Lymphoman
Loretta Fala
Loretta Fala
Read More
Online Only
FDA Approvals
Jemperli (Dostarlimab) First Immunotherapy Approved for Recurrent or Advanced Mismatch Repair-Deficient Endometrial Cancer
Loretta Fala
Loretta Fala
Read More
Online Only
FDA Approvals
Abecma (Idecabtagene Vicleucel) First-in-Class BCMA-Directed CAR T-Cell Therapy Approved for Relapsed or Refractory Multiple Myeloma
Loretta Fala
Loretta Fala
Read More
Online Only
FDA Approvals
Truseltiq (Infigratinib) New Targeted Therapy FDA Approved for Advanced or Metastatic Cholangiocarcinoma Harboring FGFR2 Alterations
Loretta Fala
Loretta Fala
Read More
Online Only
Perspectives
Politics and Healthcare: Drug Pricing Dynamics Leading Up to the 2020 Election
Gary Branning, MBA, Kathryn Hayes, BA
Gary Branning, MBA; Kathryn Hayes, BA
Read More

Results 1 - 10 of 10
SUBSCRIBE
Copyright © Amplity Medical Communications. All rights reserved.